Market closed

OraSure Technologies/$OSUR

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About OraSure Technologies

OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.

Ticker

$OSUR
Sector
Health Care
Trading on
NASDAQ

Industry

Health Care Equipment & Supplies
Headquarters
Bethlehem, United States

Employees

638
Website
www.orasure.com

OSUR Metrics

BasicAdvanced
$276M
24.49
$0.15
0.04
-

$276M

0.04

$8.33

$3.52

949K

12.603

10.996

2.241

2.61

1.06%

2.74%

24.495

1.223

0.65

0.71

4.285

-50.46%

-77.05%

-1.26%

-1.26%

What the Analysts think about OSUR

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for OraSure Technologies stock.

OSUR Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

OSUR Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-

OSUR News

AllArticlesVideos
OraSure to Present at the J.P Morgan Healthcare Conference

OraSure to Present at the J.P Morgan Healthcare Conference

GlobeNewsWire·1 week ago
CORRECTION - OraQuick® HIV Self-Test Now Approved for Use in Adolescents

CORRECTION - OraQuick® HIV Self-Test Now Approved for Use in Adolescents

GlobeNewsWire·1 week ago
OraQuick® HIV Self-Test Now Approved for Use in Adolescents

OraQuick® HIV Self-Test Now Approved for Use in Adolescents

GlobeNewsWire·1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $OSUR

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for OraSure Technologies stock?

OraSure Technologies (OSUR) has a market cap of $276M as of January 15, 2025.

What is the P/E ratio for OraSure Technologies stock?

The price to earnings (P/E) ratio for OraSure Technologies (OSUR) stock is 24.49 as of January 15, 2025.

Does OraSure Technologies stock pay dividends?

No, OraSure Technologies (OSUR) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next OraSure Technologies dividend payment date?

OraSure Technologies (OSUR) stock does not pay dividends to its shareholders.

What is the beta indicator for OraSure Technologies?

OraSure Technologies (OSUR) has a beta rating of 0.04. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.